The Effect of Virtual Reality on Pain and Memory.
Launched by UNIVERSITY OF WASHINGTON · Mar 6, 2025
Trial Information
Current as of May 09, 2025
Completed
Keywords
ClinConnect Summary
The primary outcome measure was the participants' accuracy of remembering the pattern of a total of five pain stimuli per set. Using the Quantitative Sensory Testing "method of limits", each participant selected a temperature they found "painful but tolerable" that they were willing to receive several more times, later in the study. They then received a sequence of five brief stimuli to their wrist, with a brief inter-stimulus interval between each stimulus.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • must be English speaking (but English does not necessarily need to be native/first language).
- • must be willing to follow our UW approved instructions,
- Exclusion Criteria:
- • Not capable of indicating pain intensity
- • Not capable of filling out study measures
- • Non-English-speaking
- • Extreme susceptibility to motion sickness
- • Seizure history
- • Unusual sensitivity or lack of sensitivity to pain
- • Sensitive skin
- • sensitive feet
- • migraines
- • cold symptoms
- • Diabetes
- • Or if you are under 18 years old
About University Of Washington
The University of Washington (UW) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust network of interdisciplinary teams, UW fosters collaboration among top-tier researchers, clinicians, and healthcare professionals, aiming to translate scientific discoveries into impactful treatments and interventions. The university is dedicated to ethical research practices and participant safety, ensuring rigorous adherence to regulatory standards in all clinical trials. Through its state-of-the-art facilities and extensive expertise, UW strives to address pressing health challenges and improve patient outcomes on a local and global scale.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seattle, Washington, United States
Patients applied
Trial Officials
Hunter G Hoffman, Ph.D.
Principal Investigator
University of Washington
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported